Craft

AngioDynamics

Stock Price

$5.8

2024-04-30

Market Capitalization

$231.9 M

2024-04-30

Revenue

$338.8 M

FY, 2023

AngioDynamics Summary

Company Summary

Overview
AngioDynamics is a provider of medical devices. It specializes in vascular, peripheral vascular, and oncology medicine. The company offers AngioVac System, for the non-surgical removal of right heart vegetation; AlphaVac system, an emergent mechanical aspiration device; NanoKnife 3.0 System, which offers a reimagined approach to localized therapy; and other products.
Type
Public
Status
Active
Founded
1988
HQ
Latham, NY, US | view all locations
Website
https://www.angiodynamics.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Jim Clemmer

    Jim Clemmer, President, Chief Executive Officer and Director

    • Steve Trowbridge

      Steve Trowbridge, Executive Vice President, Chief Financial Officer

    • Benjamin Davis

      Benjamin Davis, Senior Vice President, Business Development, Strategy and R&D

    • Warren Nighan

      Warren Nighan, Senior Vice President, Quality, Regulatory Affairs

      Operating MetricsView all

      Manufacturing Facilities

      2

      FY, 2023

      Manufacturing Facilities, sq. ft.

      156K
      33.6%

      FY, 2023

      Research and Development Centers

      2

      FY, 2023

      LocationsView all

      8 locations detected

      • Latham, NY HQ

        United States

        14 Plaza Dr

      • Glens Falls, NY

        United States

        8 Glens Falls Tech Park

      • Marlborough, MA

        United States

        26 Forest St

      • Queensbury, NY

        United States

        603 Queensbury Ave

      • Oakville, ON

        Canada

        2275 Upper Middle Rd E #101

      • Hong Kong, Hong Kong Island

        Hong Kong

        Suite 6, 6/F Luk Kwok Centre 72 Gloucester Road

      and 2 others

      AngioDynamics Financials

      Summary Financials

      Revenue (Q3, 2024)
      $75.2M
      Gross profit (Q3, 2024)
      $35.9M
      Net income (Q3, 2024)
      ($187.7M)
      Cash (Q3, 2024)
      $78.5M
      EBIT (Q3, 2024)
      ($199.9M)

      Footer menu